Why BIAF was halted on Sep 17 2026: hong kong patent
BIAF+100.0%on Thu Sep 17 2026
bioAffinity Technologies, Inc. Common Stock was up 100.0% on the day at $10.70, ranked #1 on 388× its usual five-minute volume, when TapeRank recorded this trading halt at 12:26 ET during regular hours when it was halted.
WHAT THE ROW LOOKED LIKE
LAST10.70
DAY▲ 100.0%
5 MIN▲ 11.81%
5M RVOL388×
5M $VOL$14.8M
FLOAT*592K
RANK#1
SESSIONREGULAR
* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
AI VERDICT
STRETCHEDCONFIDENCE5/5
BIAF is up 55.3% on news that Hong Kong granted a patent for its lung-cancer detection platform. The patent adds intellectual-property protection and potential Asian-market positioning, but provides no disclosed revenue, approval, or commercial milestone to support a move of this size.
WHYA 55.3% rally is far larger than the immediate economic impact of a single regional patent grant with no quantified commercial terms.
ANALYZED 12:09 ET · 17 MIN AGO · OPENAI/GPT-5.6-LUNA
FILINGS · 24H BEFORE THE MOVE
- 08:04 ETHong Kong Intellectual Property Department Grants Patent For bioAffinity’s Proprietary Platform Technology For Predicting Likelihood Of Lung Cancer Using Flow Cytometry And Fluorescent Markers To Characterize Cell Populations In SputumBenzinga
- 04:30 ET8-K — Other Events; Financial Statements and ExhibitsSEC 8-K
SESSION LEVELS AT CAPTURE
VWAP7.76
HOD10.70
LOD6.45
OR HIGH—
OR LOW—
PREV CLOSE5.35
PM HIGH—
PM LOW—
GAP▲ 30.84%
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO